Semler Scientific (NASDAQ:SMLR) Now Covered by Analysts at Maxim Group

Maxim Group started coverage on shares of Semler Scientific (NASDAQ:SMLR - Get Free Report) in a research report issued on Wednesday,Benzinga reports. The firm set a "buy" rating and a $95.00 price target on the stock. Maxim Group's price objective suggests a potential upside of 124.48% from the company's previous close.

Other equities analysts have also issued reports about the stock. Benchmark initiated coverage on shares of Semler Scientific in a research report on Tuesday. They set a "buy" rating and a $101.00 target price on the stock. Wall Street Zen lowered shares of Semler Scientific from a "buy" rating to a "sell" rating in a research report on Thursday, May 22nd.

Semler Scientific Stock Up 1.5%

Semler Scientific stock traded up $0.61 during mid-day trading on Wednesday, hitting $42.32. The company had a trading volume of 880,020 shares, compared to its average volume of 561,165. The stock has a market cap of $579.36 million, a price-to-earnings ratio of -16.21 and a beta of 1.39. Semler Scientific has a 1 year low of $21.77 and a 1 year high of $81.56. The company has a quick ratio of 0.51, a current ratio of 0.52 and a debt-to-equity ratio of 0.59. The business has a fifty day moving average of $37.03 and a 200 day moving average of $42.35.

Semler Scientific (NASDAQ:SMLR - Get Free Report) last announced its quarterly earnings results on Tuesday, May 13th. The company reported ($0.76) EPS for the quarter. The company had revenue of $8.84 million during the quarter. Semler Scientific had a negative net margin of 60.69% and a positive return on equity of 19.75%.

Institutional Investors Weigh In On Semler Scientific

Hedge funds have recently modified their holdings of the stock. GAMMA Investing LLC lifted its holdings in shares of Semler Scientific by 49,133.3% during the first quarter. GAMMA Investing LLC now owns 7,385 shares of the company's stock worth $267,000 after purchasing an additional 7,370 shares during the period. Wells Fargo & Company MN lifted its holdings in shares of Semler Scientific by 618.3% during the fourth quarter. Wells Fargo & Company MN now owns 103,465 shares of the company's stock worth $5,587,000 after purchasing an additional 89,060 shares during the period. Charles Schwab Investment Management Inc. lifted its holdings in shares of Semler Scientific by 11.0% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 48,625 shares of the company's stock worth $2,626,000 after purchasing an additional 4,802 shares during the period. Nuveen Asset Management LLC lifted its holdings in shares of Semler Scientific by 396.9% during the fourth quarter. Nuveen Asset Management LLC now owns 124,548 shares of the company's stock worth $6,726,000 after purchasing an additional 99,482 shares during the period. Finally, MetLife Investment Management LLC acquired a new stake in shares of Semler Scientific during the fourth quarter worth $163,000. 49.37% of the stock is owned by institutional investors and hedge funds.

About Semler Scientific

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.